Promising therapeutic efficacy of kolaviron against prenatal valproate-induced autism spectrum disorder
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 29، شماره: 8
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 31
فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-29-8_006
تاریخ نمایه سازی: 14 مرداد 1405
چکیده مقاله:
Objective(s): Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition marked by impairments in social communication, language, and behavior. Prenatal exposure to valproic acid (VPA) contributes to its pathogenesis. kolaviron (KV), a polyphenolic extract from Garcinia kola, has potent antioxidant and anti-inflammatory properties, offering neuroprotective potential in ASD models. Our study aimed to evaluate whether KV could improve the VPA-induced autism model through targeting serotonergic system, mitochondrial dysregulation, oxidative stress, and inflammation.Materials and Methods: Pregnant Wistar rats received a single intraperitoneal dose of VPA (۶۰۰ mg/kg) on gestational day ۱۲.۵ to induce autism-like features in offspring. Male pups were weaned on postnatal day (PND) ۲۱ and randomly assigned to receive KV (۵۰ or ۱۰۰ mg/kg, oral), or saline until PND ۴۹. Behavioral tests were finally conducted and brain tissue was collected for analysis of hippocampal oxidative stress, mitochondrial dysfunction, serotonin transporter (۵-HTT), serotonin receptor ۷ (۵-HTR۷), tumor necrosis factor α (TNF), and interleukin ۶ (IL-۶) levels. Immunohistochemical staining for glial fibrillary acidic protein (GFAP) was also performed to assess astrocytic reaction.Results: KV-treated VPA-exposed rats showed significant improvements in social interaction and with lower repetitive behavior. Biochemically, KV decreased malondialdehyde (MDA), IL-۶ and TNFα levels, improved catalase activity and mitochondrial membrane potential (MMP), and modulated serotonergic markers (۵-HTT and ۵-HTR۷). Histologically, KV also attenuated hippocampal GFAP immunoreactivity (IRA). Conclusion: KV showed its promising potential as a complementary therapeutic agent in ASD murine model. Further studies are still warranted to clarify its further mechanisms and clinical relevance.
کلیدواژه ها:
نویسندگان
Vahid Khodashenas
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Tourandokht Baluchnejadmojarad
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Mitra Farbin
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Ali Khodabakhshi Korelaei
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Soraya Mehrabi
Cellular and Molecular Research Center, Iran university of Medical Sciences, Tehran, Iran
Mehrdad Roghani
Neurophysiology Research Center, Shahed University, Tehran, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :